Emerging treatments for mesothelioma can be modified versions of existing ones or entirely new therapies altogether. New mesothelioma treatments are currently being studied in clinical trials across the country. Examples of emerging mesothelioma treatments include: Immunotherapy Gene therapy Vaccine therapy Stu...
New and old treatments for malignant mesothelioma: not just immunotherapydoi:10.1016/S2213-2600(20)30516-6Anna K NowakThe Lancet Respiratory Medicine
"People living with mesothelioma often tell us that among their first reactions to diagnosis is despair at the lack of treatment available. We hope that the progress being made in research we fund will soon provide new treatments and new hope for patients."...
“We are very excited about this discovery and are extremely pleased that it was also chosen to be the featured cover story,” said Yang. “The next step is to translate this discovery into actual treatments formesotheliomapatients.” The discovery outlines the process causing the growth of meso...
medical advancements involving stem cells are certainly groundbreaking and encouraging; it seems like it is a matter of time before they are linked to helping even more medical conditions. By staying abreast of research on stem cells, it will be interesting to see where the medical research goes...
This Page Contains 6 Cited Articles The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations. Centers for Disease Control and Prevention. (2022, May 13). Malign...
10A). Of note, we also have, even if preliminary, data indicating that the signature increases the response to treatment of glioma cells, suggesting an effect as a sensitizer to treatments (Fig. 10B). Altogether, our data suggest that the identified signature, having an impact on glioma ...
within PDTOs so that the latter may be classified according to their response to treatments. Applications in oncology Mechanistic and basic insights Organoids and PDTOs are increasingly being used within the scientific community, particularly for basic oncology research. Organoids have demonstrated their...
Significant advancements have been made in the application of chimeric antigen receptor (CAR)-T treatment for blood cancers during the previous ten years. However, its effectiveness in treating solid tumors is still lacking, necessitating the exploration
An international research group including scientists from Italy, the United States, Ireland, and Israel have published a three-year analysis of the Mesothelioma (Me) drug trial, Check-Mate 743 (CM-743). The trial studied the use of the combination therap